Press release
Antifibrinolytic Drugs Market Set to Record Exponential Growth by 2025
Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding. Tranexamic acid is used when the risk of hemorrhage is high because of increased fibrinolysis. Aprotinin, a proteolytic enzyme inhibitor which acts on plasmin and kallikrein. Antifibrinolytic drugs have nearly a ubiquitous use during important major surgeries when bleeding is expected most likely. The inhibition of fibrinolytic pathway after the tissue injury has constantly been showing a decrease in postoperative bleeding this ultimately results in the reduction in need of blood transfusion after an operation.Get access to full summary @: http://www.persistencemarketresearch.com/market-research/antifibrinolytic-drugs-market.asp
Global Antifibrinolytic Drugs Market: Dynamics
Growth in healthcare investments, the prevalence of angioedema and growing high-risk geriatric population, are the major factors driving the global market growth for angioedema treatment. In the next few years, the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.
Global Antifibrinolytic Drugs Market: Segmentation
On the basis of Indications, the Global Antifibrinolytic Drugs market can be segmented into: Gynecology, Menorrhagia, Pregnancy, Parturition, Gynecological surgery,Gastrointestinal (GI) bleeding,
Dental surgery, Haemorrhage, Bleeding disorders, Hereditary angioedema, Fibrinolytic response testing, Surgeries,Cardiac, Orthopedic, Liver, Neurosurgery. On the basis of Drug Types, the Global Antifibrinolytic Drugs market can be segmented into: Amicar, Aminocaproic acid, Aprotinin, Cyklokapron, ,Fibrinogen, human, Lysteda, RiaSTAP, Tranexamic acid injection, Tranexamic acid oral, Trasylol. On the basis of End User, the Global Antifibrinolytic Drugs market can be segmented into: Hospitals, Ambulatory Surgical Centers, Clinics, Healthcare Specialty processes, Others. On the basis of Region, the Global Antifibrinolytic Drugs market can be segmented into: North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/14035
For treating menorrhagia, Tranexamic acid is widely used and is also recommended by the current National Institute for Health and Care Excellence guidelines. Tranexamic acid is effective in decreasing the blood loss by almost 40-50%. Etamsylate is used just occasionally to treat menorrhagia.
Global Antifibrinolytic Drugs Market: Region-wise Outlook
Geographically, North America is the dominating region in the Antifibrinolytic Drugs market owing to the advancing strict rules at the work place in this region, also due to a large number of aging population and broad technical applications of Antifibrinolytic Drugs in the region. Also, rising awareness of Antifibrinolytic Drugs has fueled the Antifibrinolytic Drugs market.The US holds the prominent market in the Antifibrinolytic Drugs market in North America trailed by Europe including Germany, France, and the UK. The Asian market for Antifibrinolytic Drugs is also expected to witness a high CAGR during the coming years. Increased foreign investments in this region will also boost the Antifibrinolytic Drugs market ahead. China and Japan are projected to be the fastest-growing in the Antifibrinolytic Drugs market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/14035
Global Antifibrinolytic Drugs Market: Key Players
Currently, the global Antifibrinolytic Drugs market is highly competitive owing to the involvement of many established players. Some of the key players in the global Antifibrinolytic Drugs market are Aurobindo Pharma Ltd, Acic Fine Chems, Akorn and Xanodyne Pharmaceuticals.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antifibrinolytic Drugs Market Set to Record Exponential Growth by 2025 here
News-ID: 645243 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Antifibrinolytic
Increasing Road Accidents Fuel Growth in Antifibrinolytic Drug Market: A Signifi …
The Antifibrinolytic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Antifibrinolytic Drugs Market Size and Projected Growth Rate?
Over the past few years, there has been robust growth in the size of the antifibrinolytic drugs market. The growth from $16.82 billion in…
Antifibrinolytic Drugs Market Expected to Reach $19,333 Million by 2026 | Top Re …
According to a new report published by Allied Market Research, titled, "Antifibrinolytic Drugs Market by Indication and End User: Global opportunity analysis and industry forecast, 2019-2026," the global antifibrinolytic drugs market size is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026, in terms of value.
Antifibrinolytics are one of the most commonly used drugs to prevent fibrinolysis by blocking the activation of plasminogen…
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What market dynamics are playing a key role in accelerating the growth of the antifibrinolytic drugs market?
The escalating rate of road mishaps projects an upward trajectory for the antifibrinolytic drugs market. Causes for this surge in road accidents range from smartphone usage, excessive speed, driving while intoxicated, and poor vehicle upkeep. Antifibrinolytic medications have a critical role in managing hemorrhage in victims of road crashes by consolidating blood clots, curtailing…
Leading Growth Driver in the Antifibrinolytic Drugs Market in 2025: Increasing R …
What Are the Market Size and Growth Forecast for the Antifibrinolytic Drugs Market?
In the past few years, there has been a significant expansion in the size of the antifibrinolytic drugs market. The market, which was valued at $16.82 billion in 2024, is projected to rise to $17.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The surge in this market over the historical period is largely…
Antifibrinolytic Drugs Market Size, Share, Trends, Global Demand, Growth, Opport …
The latest research study "Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on…
Antifibrinolytic Drugs Market Opportunities and Forecasts, 2017 – 2025
Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding. Tranexamic acid is used when the risk of hemorrhage is high because of increased fibrinolysis. Aprotinin, a proteolytic enzyme inhibitor which acts on plasmin and kallikrein.…